Hudson Capital Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Hudson Capital Management’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-12,394	Closed	-$1.34M	–	84
2019 Q1	$1.34M	Buy	12,394 +1,220	+11%	+$121K	0.82%	40
2018 Q4	$946K	Buy	11,174 +1,259	+13%	+$121K	0.69%	40
2018 Q3	$975K	Buy	9,915 +687	+7%	+$74.3K	0.74%	41
2018 Q2	$1.07M	Buy	9,228 +1,235	+15%	+$136K	0.74%	42
2018 Q1	$789K	Buy	7,993 +1,261	+19%	+$128K	0.58%	51
2017 Q4	$705K	Buy	+6,732	New	+$740K	0.52%	53

Other funds holding TARO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CAM

Claret Asset Management Montreal, Quebec, Canada $928M AUM 25.4% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Hudson Capital Management's TARO Position: Q2 2019 in Review

Hudson Capital Management sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2019, closing a stake of 12,394 shares — an estimated $1.34M sold.

Hudson Capital Management first reported a position in TARO in Q4 2017 and held it in 6 quarters. The position peaked at $1.34M in Q1 2019. 105 funds tracked by Wall St. Rank hold TARO as of Q2 2019.

Hudson Capital Management reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2019 after selling out during the quarter.
Hudson Capital Management sold 12,394 Taro Pharmaceutical Industries Ltd. shares in Q2 2019, an estimated $1.34M.
Hudson Capital Management first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2017 and held it in 6 quarters.
Hudson Capital Management's Taro Pharmaceutical Industries Ltd. position peaked at $1.34M in Q1 2019.
105 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2019.

Based on Hudson Capital Management's 13F filing for Q2 2019, filed 12 Jul 2019.